Logo

financial estimates

MGI Tech Reports Preliminary 2022 Results

The Chinese next-generation sequencing instrumentation firm expects its net profit attributable to shareholders to be at least RMB 1.94 billion ($284.2 million).

Oxford Nanopore Technologies Expects 2022 Revenue to Rise 49 Percent

The company expects 2022 revenue to be approximately £199.0 million, including around £147.0 million in life science research tools revenue.

Pacific Biosciences Provides Updates on Platforms, Contracts at JP Morgan Conference

The firm won a population genomics contract in Dubai, launched a trusted partner network, and signed a bioinformatics collaboration deal.

Castle Biosciences Estimates 2022 Revenues in Line With Prior Projections

The company said it expects full-year revenues of at least $132 million to $137 million, with test volumes up significantly across the majority of its menu.

Exact Sciences Projects 28 Percent Bump in Total Q4 Oncology Revenue

The company expects to report consistent growth in both cancer screening and precision oncology testing for the quarter and the full fiscal year.

Jan 9, 2023

Sema4 Changes Name to GeneDx, Provides Preliminary 2022 Revenues, 2023 Guidance

Nov 21, 2022

Agilent Fiscal Q4 Revenues Rise 11 Percent, Full-Year 2022 Revenues Grow 8 Percent

Jul 26, 2022

Cowen Downgrades Invitae to Market Perform

Jul 18, 2022

Invitae to Lay Off Over 1,000 Workers Amid Restructuring, Leadership Transition

Jul 14, 2022

10x Genomics Preliminary Q2 Revenues Down 1 Percent

Jul 6, 2022

T2 Biosystems Reports Preliminary Drop in Q2 Revenues, Cuts Workforce

Apr 20, 2022

Abbott Q1 Diagnostics Revenues Climb 32 Percent

Apr 18, 2022

Fulgent Genetics Preliminary Q1 Revenues Exceed Guidance; Firm to Acquire Inform Diagnostics

Apr 13, 2022

NanoString Technologies Blames Q1 Underperformance on Sales Force Realignment, Uneven Execution
Premium

Apr 12, 2022

NanoString Technologies Q1 Preliminary Revenues Fall Short of Guidance

Apr 7, 2022

Meridian Bioscience Preliminary Fiscal Q2 Revenues Rise by up to 33 Percent

Mar 29, 2022

NeoGenomics Stock Plummets on Predicted Lower Q1 Expectations, Departure of CEO

Mar 14, 2022

Biodesix Q4 Revenues Decline 73 Percent on Drop in COVID-19 Testing

Jan 27, 2022

Abbott Preparing for COVID-19 Testing Uncertainty in 2022
Premium

Jan 20, 2022

Sema4 to Embrace Co-CEO Model After $623M Acquisition of GeneDx
Premium

Jan 13, 2022

Quanterix Projects Q4 2021 Revenues of $29M to $31M

Jan 11, 2022

PacBio Prelim Q4 Revenues up 33 Percent; Firm Partners With Google, Berry Genomics, Genomics England

Jan 11, 2022

Danaher, PerkinElmer, Cue Health, Others Announce Preliminary Q4 Earnings Results

Jan 11, 2022

Illumina Touts New Partnerships, Sequencing Technology at JP Morgan Healthcare Conference

Jan 10, 2022

Exact Sciences Projects up to $475M in Q4 Revenues, Acquires Testing Lab, Inks Licensing Deal

Breaking News
The Scan

Genetic Testing Approach Explores Origins of Blastocyst Aneuploidy

Investigators in AJHG distinguish between aneuploidy events related to meiotic missegregation in haploid cells and those involving post-zygotic mitotic errors and mosaicism.

Study Looks at Parent Uncertainties After Children's Severe Combined Immunodeficiency Diagnoses

A qualitative study in EJHG looks at personal, practical, scientific, and existential uncertainties in parents as their children go through SCID diagnoses, treatment, and post-treatment stages.

Antimicrobial Resistance Study Highlights Key Protein Domains

By screening diverse versions of an outer membrane porin protein in Vibrio cholerae, researchers in PLOS Genetics flagged protein domain regions influencing antimicrobial resistance.

Latent HIV Found in White Blood Cells of Individuals on Long-Term Treatments

Researchers in Nature Microbiology find HIV genetic material in monocyte white blood cells and in macrophages that differentiated from them in individuals on HIV-suppressive treatment.